- Tytuł:
- Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial
- Autorzy:
- Źródło:
- In The Lancet 4-10 November 2017 390(10107):2073-2082
Czasopismo naukowe